• Exchange: Stockholm
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma


104.5000 SEK 0.1000 0.10%

As of 11:29:59 ET on 11/25/2014.

Snapshot for Meda AB (MEDAA)

Open: 104.3000 Day's Range: 103.7000 - 105.3000 Volume: 1,085,783
Previous Close: 104.6000 52wk Range: 74.0982 - 125.1671 1-Yr Rtn: +43.09%

Stock Chart for MEDAA

No chart data available.
  • MEDAA:SS 104.5000
  • 1D
  • 1M
  • 1Y
Interactive MEDAA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MEDAA

Current P/E Ratio (ttm) 35.0975
Estimated P/E(12/2014) 32.7176
Relative P/E vs. OMX 2.1634
Earnings Per Share (SEK) (ttm) 2.9774
Est. EPS (SEK) (12/2014) 3.1940
Est. PEG Ratio 1.3230
Market Cap (M SEK) 38,191.34
Shares Outstanding (M) 365.47
30 Day Average Volume 967,091
Price/Book (mrq) 2.0953
Price/Sale (ttm) 2.4017
Dividend Indicated Gross Yield 2.31%
Cash Dividend (SEK) 2.4089
Dividend Ex-Date 05/08/2014
5 Year Dividend Growth 27.23%
Next Earnings Announcement 02/11/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MEDAA

  • Revenue
  • Net Income (M/SEK)
  • Profit Margin (%)

Company Profile & Key Executives for MEDAA

Meda AB is a specialty pharmaceutical company. The Company imports and markets pharmaceuticals, nutritional, and health-care products, and offers services including clinical research, registration, and logistics. Meda's products are sold in the Nordic countries and in the Baltic states on behalf of foreign manufacturers. The Company markets to wholesale dealers and hospitals.

Henrik StenqvistExec VP/CFOMaria CarellExec VP:North America
Dirk GroenExec VP:Marketing OTCErik HaefflerExec VP:Manufacturing
More Company Profile & Key Executives for MEDAA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil